Acta Diabetologica·1 OctBridging the gap in early cardio-renal risk prevention in type 2 diabetes: evidence, guidelines, and real-world insights from the PRECARE NO LiMITS initiativeStudy in peopleType 2 diabetesPaper
JAMA Cardiology·16 SepEfficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical TrialRandomised trial in 17,604 peopleSemaglutidePaper